List of amyotrophic lateral sclerosis patents

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9713503 Surgical utility connector	Patent 9713503 was granted and assigned to Novartis on July, 2017 by the United States Patent and Trademark Office.	Novartis	Novartis	United States Patent and Trademark Office	9713503	July 25, 2017
‌ US Patent 9072587 Surgical variable-angle illuminator	Patent 9072587 was granted and assigned to Novartis on July, 2015 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	9072587	July 7, 2015
‌ US Patent 8147728 Pad transfer printing of silicone hydrogel lenses using colored ink	Patent 8147728 was granted and assigned to Novartis on April, 2012 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	8147728	April 3, 2012
‌ US Patent 7531511 Method for inducing angiogenesis or vascular perfusion in the myocardium comprising administering FGF-2	Patent 7531511 was granted and assigned to Novartis on May, 2009 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	7531511	May 12, 2009
‌ US Patent 7468390 Methods of treatment and pharmaceutical composition	Patent 7468390 was granted and assigned to Novartis on December, 2008 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	7468390	December 23, 2008
‌ US Patent 9844321 Enhanced ophthalmic surgical experience using a virtual reality head-mounted display	Patent 9844321 was granted and assigned to Novartis on December, 2017 by the United States Patent and Trademark Office.	Novartis	Novartis	United States Patent and Trademark Office	9844321	December 19, 2017
‌ US Patent 10016248 Ophthalmic illumination profiles and associated devices, systems, and methods	Patent 10016248 was granted and assigned to Novartis on July, 2018 by the United States Patent and Trademark Office.	Novartis	Novartis	United States Patent and Trademark Office	10016248	July 10, 2018
‌ US Patent 8734832 Microemulsions with adsorbed macromolecules and microparticles	Patent 8734832 was granted and assigned to Novartis on May, 2014 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	8734832	May 27, 2014
‌ US Patent 7432250 Oligoribonucleotides and ribonucleases for cleaving RNA	Patent 7432250 was granted and assigned to Ionis Pharmaceuticals on October, 2008 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7432250	October 7, 2008
‌ US Patent 10081697 Hydrophilized polydiorganosiloxane vinylic crosslinkers and uses thereof	Patent 10081697 was granted and assigned to Novartis on September, 2018 by the United States Patent and Trademark Office.	Novartis	Novartis	United States Patent and Trademark Office	10081697	September 25, 2018
‌ US Patent 8443978 Package for medicament	Patent 8443978 was granted and assigned to Novartis on May, 2013 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	8443978	May 21, 2013
‌ US Patent 10301451 Chain-extended polydimethylsiloxane vinylic crosslinkers and uses thereof	Patent 10301451 was granted and assigned to Novartis on May, 2019 by the United States Patent and Trademark Office.	Novartis	Novartis	United States Patent and Trademark Office	10301451	May 28, 2019
‌ US Patent 9221913 Silent Fc variants of anti-CD40 antibodies	Patent 9221913 was granted and assigned to Novartis on December, 2015 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	9221913	December 29, 2015
‌ US Patent 7432249 Oligoribonucleotides and ribonucleases for cleaving RNA	Patent 7432249 was granted and assigned to Ionis Pharmaceuticals on October, 2008 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7432249	October 7, 2008
‌ US Patent 7101993 Oligonucleotides containing 2′-O-modified purines	Patent 7101993 was granted and assigned to Ionis Pharmaceuticals on September, 2006 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7101993	September 5, 2006
‌ US Patent 7696345 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation	Patent 7696345 was granted and assigned to Ionis Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7696345	April 13, 2010
‌ US Patent 11040107 Dosing regimens and related compositions and methods	Patent 11040107 was granted and assigned to Apellis Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.		Apellis Pharmaceuticals	United States Patent and Trademark Office	11040107	June 22, 2021
‌ US Patent 10092007 Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom	Patent 10092007 was granted and assigned to Clene Nanomedicine on October, 2018 by the United States Patent and Trademark Office.		Clene Nanomedicine	United States Patent and Trademark Office	10092007	October 9, 2018
‌ US Patent 10327632 Systems and methods for wide field-of-view optical coherence tomography	Patent 10327632 was granted and assigned to Novartis on June, 2019 by the United States Patent and Trademark Office.	Novartis	Novartis	United States Patent and Trademark Office	10327632	June 25, 2019
‌ US Patent 9555200 Inhaler	Patent 9555200 was granted and assigned to Novartis on January, 2017 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	9555200	January 31, 2017
‌ US Patent 9097840 Amphiphilic siloxane-containing (meth)acrylamides and uses thereof	Patent 9097840 was granted and assigned to Novartis on August, 2015 by the United States Patent and Trademark Office.	Novartis	Novartis	United States Patent and Trademark Office	9097840	August 4, 2015
‌ US Patent 9428739 Norovirus and Sapovirus antigens	Patent 9428739 was granted and assigned to Novartis on August, 2016 by the United States Patent and Trademark Office.	Novartis	Novartis	United States Patent and Trademark Office	9428739	August 30, 2016
‌ US Patent 9612455 Extended wear ophthalmic lens	Patent 9612455 was granted and assigned to Novartis on April, 2017 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	9612455	April 4, 2017
‌ US Patent 8217035 Pyrimidine derivatives used as PI-3-kinase inhibitors	Patent 8217035 was granted and assigned to Novartis on July, 2012 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	8217035	July 10, 2012
‌ US Patent 7629321 Oligoribonucleotides and ribonucleases for cleaving RNA	Patent 7629321 was granted and assigned to Ionis Pharmaceuticals on December, 2009 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7629321	December 8, 2009

...

Results per page:

4,433 results

0 selected

4,433 results

0 selected